Literature DB >> 35859859

A New Chemotype of Chemically Tractable Nonsteroidal Estrogens Based on a Thieno[2,3-d]pyrimidine Core.

Vamshikrishna Reddy Sammeta1, John D Norris2, Sandeep Artham2, Chad D Torrice2, Jovita Byemerwa2, Carstyn Joiner3, Sean W Fanning3, Donald P McDonnell2, Timothy M Willson1.   

Abstract

Despite continued interest in the development of nonsteroidal estrogens and antiestrogens, there are only a few chemotypes of estrogen receptor ligands. Using targeted screening in a ligand sensing assay, we identified a phenolic thieno[2,3-d]pyrimidine with affinity for estrogen receptor α. An efficient three-step synthesis of the heterocyclic core and structure-guided optimization of the substituents resulted in a series of potent nonsteroidal estrogens. The chemical tractability of the thieno[2,3-d]pyrimidine chemotype will support the design of new estrogen receptor ligands as therapeutic hormones and antihormones.
© 2022 American Chemical Society.

Entities:  

Year:  2022        PMID: 35859859      PMCID: PMC9290010          DOI: 10.1021/acsmedchemlett.2c00180

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.632


  23 in total

1.  Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

Authors:  L A Paige; D J Christensen; H Grøn; J D Norris; E B Gottlin; K M Padilla; C Y Chang; L M Ballas; P T Hamilton; D P McDonnell; D M Fowlkes
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Kinase inhibitor selectivity profiling using differential scanning fluorimetry.

Authors:  Oleg Fedorov; Frank H Niesen; Stefan Knapp
Journal:  Methods Mol Biol       Date:  2012

3.  Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesis.

Authors:  Anthony J Roecker; Swati P Mercer; C Meacham Harrell; Susan L Garson; Steven V Fox; Anthony L Gotter; Thomayant Prueksaritanont; Tamara D Cabalu; Donghui Cui; Wei Lemaire; Christopher J Winrow; John J Renger; Paul J Coleman
Journal:  Bioorg Med Chem Lett       Date:  2014-03-26       Impact factor: 2.823

Review 4.  Minireview: Estrogen receptor-beta: mechanistic insights from recent studies.

Authors:  Bonnie J Deroo; Adrian V Buensuceso
Journal:  Mol Endocrinol       Date:  2010-04-02

5.  Peptide antagonists of the human estrogen receptor.

Authors:  J D Norris; L A Paige; D J Christensen; C Y Chang; M R Huacani; D Fan; P T Hamilton; D M Fowlkes; D P McDonnell
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

Review 6.  Estrogen Hormone Biology.

Authors:  Katherine J Hamilton; Sylvia C Hewitt; Yukitomo Arao; Kenneth S Korach
Journal:  Curr Top Dev Biol       Date:  2017-02-03       Impact factor: 4.897

Review 7.  Endocrine modulators in the food chain and environment.

Authors:  R Nilsson
Journal:  Toxicol Pathol       Date:  2000 May-Jun       Impact factor: 1.902

8.  Discovery of potent thieno[2,3-d]pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations.

Authors:  Eman Z Elrazaz; Rabah A T Serya; Nasser S M Ismail; Amgad Albohy; Dalal A Abou El Ella; Khaled A M Abouzid
Journal:  Bioorg Chem       Date:  2021-05-30       Impact factor: 5.275

Review 9.  Sources of estrogen and their importance.

Authors:  E R Simpson
Journal:  J Steroid Biochem Mol Biol       Date:  2003-09       Impact factor: 4.292

10.  The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells.

Authors:  Sean W Fanning; Rinath Jeselsohn; Venkatasubramanian Dharmarajan; Christopher G Mayne; Mostafa Karimi; Gilles Buchwalter; René Houtman; Weiyi Toy; Colin E Fowler; Ross Han; Muriel Lainé; Kathryn E Carlson; Teresa A Martin; Jason Nowak; Jerome C Nwachukwu; David J Hosfield; Sarat Chandarlapaty; Emad Tajkhorshid; Kendall W Nettles; Patrick R Griffin; Yang Shen; John A Katzenellenbogen; Myles Brown; Geoffrey L Greene
Journal:  Elife       Date:  2018-11-29       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.